Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
134 participants
INTERVENTIONAL
2015-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effects of a Structured Education Program on Blood Pressure in Essential Hypertensive Patients
NCT00453037
Awareness Program on Knowledge Regarding Prevention of Hypertensive Crisis
NCT06986746
Blood Pressure (BP) Visit Intensification Study
NCT02164331
Sports in Hypertension of the Elderly
NCT00315224
Hypertension Approaches in the Elderly: a Lifestyle Study
NCT03264443
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Education program
Group of patients participating in the interactive hypertension education program of the DHL© "My blood pressure - OK!"
Interactive hypertension education program of the DHL©
Controls
Group of patients not participating in the interactive hypertension education program of the DHL© "My blood pressure - OK!" ("usual care")
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Interactive hypertension education program of the DHL©
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Primary arterial hypertension
* Office blood pressure between 140/90 mmHg and 160/100 mmHg
Exclusion Criteria
* Unstable clinical condition
* Secondary arterial hypertension
* Dementia
* Major disability (modified Rankin-Scale \> 4)
* Severe chronic kidney disease (serum creatinine \> 2.0 mg/dL or estimated glomerular filtration rate \< 40 ml/min/1.73m2)
* Liver disease including history of hepatic encephalopathy, esophageal varices or portacaval shunt
* History of gastrointestinal operation or disease with a potential influence on drug absorption
* Allergy or other contraindications against drugs given during the study
* History of non-compliance
22 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Charite University, Berlin, Germany
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Reinhold Kreutz
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Reinhold Kreutz, Professor
Role: PRINCIPAL_INVESTIGATOR
Charite University, Berlin, Germany
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Herz- und Diabeteszentrum Ruhr-Universität Bochum
Bad Oeynhausen, North Rhine-Westphalia, Germany
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Siegfried Eckert, MD
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
DHL-HEP1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.